Professor & HOD
Qualification: M. Pharm., Ph.D.
Specialization: Pharmaceutics Email ID: yogeeta.goyal@svkm.ac.in
Phone: +91-9421270813
Experience: 16 Years
Interest Areas: Nanotechnology
Research:
Industry Projects:
Completed: Nil
Ongoing: Nil
Conferences/Workshops/Seminars attended: 42
Academic Activities:
Ph.D.: Awarded: Nil Registered: 05
M. Pharm Guided: 21
B. Pharm Guided: 40
Awards:
Professional Membership:
1. Indian Pharmaceutical Association (Life Time membership MAH/DHUL/LM/0032)
2. The Association of Pharmaceutical Teachers of India (Life Time membership MA/LM-2494)
3. Registered Pharmacist under Maharashtra State Pharmacy Council (Certificate No-74757)
4. MSU Pharmacy Alumni Association (Life time membership)
Recent Publications:
1. Premkumar S. Baviskar, Hitendra S. Mahajan, Sachin M. Chandankar, Yogeeta O. Agrawal, Development and evaluation of N-acetyl glucosamine-decorated vitamin-E-based micelles incorporating resveratrol for cancer therapy,Journal of Drug Delivery Science and Technology,Volume 78,2022,103965,ISSN 1773-2247.(Impact Factor 5.062)
2. Yogeeta O. Agrawal, Kiran D. Patil, Kamini R. More, Mohd Usman Mohd Siddique, Saad Alkahtani, Nada H. Aljarba, Md Saquib Hasnain, Amelioration of bioavailability through formulating and optimizing Azilsartan Entrapped nanostructured lipid carriers and its pharmacokinetic assessment,Journal of Drug Delivery Science and Technology,Volume 77,2022,103894,ISSN 1772247.(Impact Factor 5.062)
3. Prajapati C, Agrawal YO, Agnihotri VV, Mahajan UB, Patil KR, Patil DD, Patil CR. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis. Int J Biol Macromol. 2022 Aug 1;214:391-401.(Impact factor 8.025)
4. Agrawal YO, Husain M, Patil KD, Sodgir V, Patil TS, Agnihotri VV, Mahajan HS, Sharma C, Ojha S, Goyal SN. Verapamil hydrochloride loaded solid lipid nanoparticles: Preparation, optimization, characterisation, and assessment of cardioprotective effect in experimental model of myocardial infarcted rats. Biomed Pharmacother. 2022 Oct; 154: 113429. (Impact factor 7.419)
5. Shirsath K, Agrawal YO, Nose to brain targeting of Nanoemulsions for Parkinson’s disease: Pathways, Challenges, and recent techniques. CNS & Neurological Disorders - Drug Targets, Accepted (Impact factor 4.388)
6. Husain M, Agnihotri VV, Goyal SN, Agrawal YO, Development, optimization and characterization of hydrocolloid based mouth dissolving film of Telmisartan for the treatment of hypertension, Food Hydrocolloids for Health, Volume 2,2022,100064
7. Agrawal YO, Patil P, Patil K, Mahajan HS, Shah D, Gujarathi N. Development, Characterization, In-vitro and pharmacokinetic evaluation of Xa inhibitor Apixaban Loaded Nanostructured Lipid Carriers Optimized by Quality-By-Design Approach, Accepted, Drug Delivery, 2022 Jan 3 (Impact Factor-6.64)
8. Pawar HD, Mahajan UB, Nakhate KT, Agrawal YO, Patil CR, Meeran MFN, Sharma C, Ojha S, Goyal SN. Curcumin Protects Diabetic Mice against Isoproterenol-Induced Myocardial Infarction by Modulating CB2 Cannabinoid Receptors. Life. 2022; 12(5):624. https://doi.org/10.3390/life12050624 (Impact Factor-3.817)
9. Eddin LB, Jha NK, Goyal SN, Agrawal YO, Subramanya SB, Bastaki SMA, Ojha S. Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol. Nutrients. 2022 Mar 25;14(7):1370. doi: 10.3390/nu14071370. (Impact Factor-5.719)
10. Agrawal Y, Patil K, Mahajan H, Potdar M, Joshi P, Nakhate K, Sharma C, Goyal SN, Ojha S. In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-designapproach, Drugdelivery,29,1(2022):1112-1121. doi:10.1080/10717544.2022.2058651 (Impact Factor-6.64)
11. Husain M, Agrawal YO. Antimicrobial Remedies and Emerging Strategies for the Treatment of Diabetic Foot Ulcers, Accepted, Current Diabetes Reviews, 24 Jan 2022
12. Agrawal YO, Mahajan UB, Agnihotri VV, Nilange MS, Mahajan HS, Sharma C, Ojha S, Patil CR, Goyal SN. Ezetimibe-Loaded Nanostructured Lipid Carrier Based Formulation Ameliorates Hyperlipidaemia in an Experimental Model of High Fat Diet. Molecules. 2021 Mar 9;26(5):1485 (Impact factor-3.267)
13. Agrawal YO., Mahajan H.S., Mahajan U. B, Ojha S.Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies. Int J Nanomedicine 2020 Jul 7; 15:4763-4778. (Impact factor-5.12)
14. Redasani VK, Agrawal YO, Jagtap MS, Mahajan HS and Surana SJ. Analytical Method Development and Validation of Flecainide Acetate by Chromatographic and Spectrophotometric Techniques. Medicinal and Analytical chemistry 2020 December 08;4(2): ISSN 2639-2534.